Vivos Therapeutics Inc.

NASDAQ: VVOS · Real-Time Price · USD
4.61
0.00 (0.00%)
At close: Aug 14, 2025, 3:59 PM
4.39
-4.77%
Pre-market: Aug 15, 2025, 08:53 AM EDT

Vivos Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-1.93 -1.12 -0.41 -2.35
PEG Ratio
0.02 0.02 -0.13 -0.02
PS Ratio
1.43 1.10 0.58 2.83
PB Ratio
2.71 36.91 1.93 1.87
P/FCF Ratio
-1.62 -1.19 -0.45 -2.63
P/OCF Ratio
-1.7 -1.27 -0.47 -3.04
OCF/S Ratio
-0.84 -0.87 -1.22 -0.93
Debt / Equity Ratio
0.19 4.85 0.50 0.06
Quick Ratio
1.50 0.34 0.80 3.64
Current Ratio
1.50 0.34 0.80 3.64
Asset Turnover
0.98 1.29 1.17 0.50
Interest Coverage
n/a n/a n/a -1.39K
Return on Equity
-1.4 -33.05 -4.72 -0.79
Return on Assets
-0.73 -1.27 -1.65 -0.6
Return on Invested Capital
-0.99 -3.64 -3.07 -0.71
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
0.60 0.60 0.63 0.75
Net Profit Margin
-0.74 -0.98 -1.41 -1.2
Pretax Profit Margin
-0.74 -0.98 -1.49 -1.2
Operating Profit Margin
-0.74 -1.25 -1.56 -1.15
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-0.7 -1.21 -1.52 -1.16